Viewing Study NCT01401959


Ignite Creation Date: 2025-12-24 @ 2:31 PM
Ignite Modification Date: 2026-01-26 @ 12:16 PM
Study NCT ID: NCT01401959
Status: COMPLETED
Last Update Posted: 2018-06-15
First Post: 2011-07-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Sponsor: SCRI Development Innovations, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Breast Cancer View
None Adjuvant View
None Residual Disease View
None eribulin View
None Trastuzumab View